{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:55:29Z","timestamp":1792788929359,"version":"4.5.0"},"reference-count":82,"publisher":"Informa UK Limited","issue":"10","funder":[{"name":"Sanofi and Regeneron Pharmaceuticals, Inc."}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.2217\/imt.15.69","type":"journal-article","created":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T09:47:25Z","timestamp":1448358445000},"page":"1043-1058","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":87,"title":["Drug Evaluation Review: Dupilumab in Atopic Dermatitis"],"prefix":"10.1080","volume":"7","author":[{"given":"Jennifer D","family":"Hamilton","sequence":"first","affiliation":[{"name":"Regeneron Pharmaceuticals, Inc.,\r777 Old Saw Mill River Rd,\rTarrytown,\rNY\r10591,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Ungar","sequence":"additional","affiliation":[{"name":"Rockefeller University,Laboratory of Investigative Dermatology,\r1230 York Ave,\rNY\r10065,\rUSA"},{"name":"Center for Excellence in Eczema and Laboratory for Inflammatory Skin Diseases,Department of Dermatology and the Immunology Institute,Icahn School of Medicine at Mount Sinai Medical Center,\r1428 Madison Ave,\rNY\r10029,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Guttman-Yassky","sequence":"additional","affiliation":[{"name":"Rockefeller University,Laboratory of Investigative Dermatology,\r1230 York Ave,\rNY\r10065,\rUSA"},{"name":"Center for Excellence in Eczema and Laboratory for Inflammatory Skin Diseases,Department of Dermatology and the Immunology Institute,Icahn School of Medicine at Mount Sinai Medical Center,\r1428 Madison Ave,\rNY\r10029,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2015,11,24]]},"reference":[{"issue":"92","key":"e_1_3_3_3_1","first-page":"44","article-title":"Diagnostic features of atopic dermatitis","volume":"60","author":"Hanifin JM","year":"1980","unstructured":"Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermatovener. (Stockholm). 60(Suppl. 92), 44\u201347 (1980).","journal-title":"Acta Dermatovener. (Stockholm)."},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.2310\/6620.2007.06034"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.10.009"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.08.031"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.07.008"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69283-0"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1522"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12784"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-0960.2000.00442.x"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.101.3.e8"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.06.041"},{"issue":"2","key":"e_1_3_3_14_1","first-page":"202","article-title":"The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma","volume":"5","author":"Bantz SK","year":"2014","unstructured":"Bantz SK, Zhu Z, Zheng T. The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. J. Clin. Cell Immunol. 5(2), 202 (2014).","journal-title":"J. Clin. Cell Immunol."},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.04.064"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.530"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.10.041"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3999(03)00572-5"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.174"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.08.008"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.11.015"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2014.11.023"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.03.023"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04635.x"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0b013e3283551da5"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.07.049"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.14-RAI-0769"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.03.030"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04636.x"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.07.012"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-011-1198-9"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401307"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.113237"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.12.007"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.04.046"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12943"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2003.02273.x"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2005.02875.x"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.04.031"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2007.11.006"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.02.017"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.83"},{"key":"e_1_3_3_43_1","first-page":"718725","article-title":"Keratinocytes under fire of proinflammatory cytokines: bona fide innate immune cells involved in the physiopathology of chronic atopic dermatitis and psoriasis","volume":"2012","author":"Bernard FX","year":"2012","unstructured":"Bernard FX, Morel F, Camu M et al. Keratinocytes under fire of proinflammatory cytokines: bona fide innate immune cells involved in the physiopathology of chronic atopic dermatitis and psoriasis. J. Allergy (Cairo). 2012, 718725 (2012).","journal-title":"J. Allergy (Cairo)."},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2010.05.001"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2013.25.4.410"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.01.020"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.03.032"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.03.041"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.03.003"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(96)80161-8"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2003.01803.x"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2001.00144.x"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314768"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/12.11.1499"},{"issue":"51","key":"e_1_3_3_55_1","first-page":"pe55","article-title":"Untangling the complex web of IL-4- and IL-13-mediated signaling pathways","volume":"1","author":"Wills-Karp M","year":"2015","unstructured":"Wills-Karp M, Finkelman FD. Untangling the complex web of IL-4- and IL-13-mediated signaling pathways. Sci. Signal. 1(51), pe55 (2015).","journal-title":"Sci. Signal."},{"issue":"12","key":"e_1_3_3_56_1","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1610-0387.2010.07497.x","article-title":"Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course \u2013 a randomized, placebo-controlled and double blind pilot study","volume":"8","author":"Heil PM","year":"2010","unstructured":"Heil PM, Maurer D, Klein B, Hultsch T, Stingl G. Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course \u2013 a randomized, placebo-controlled and double blind pilot study. J. Dtsch. Dermatol. Ges. 8(12), 990\u2013998 (2010).","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2013.05.003"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2005.00791.x"},{"key":"e_1_3_3_59_1","unstructured":"Stelara\u00ae. Prescribing information revised 03\/2014. Janssen Biotech Inc. PA USA (2014).www.stelarainfo.com\/pdf\/PrescribingInformation.pdf."},{"key":"e_1_3_3_60_1","unstructured":"Stelara 45 mg solution for injection. Summary of product characteristics last updated 23\/12\/2014. Janssen Biologics B.V. Leiden The Netherlands. www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000958\/WC500058513.pdf."},{"key":"e_1_3_3_61_1","unstructured":"Xolair\u00ae. Prescribing information revised 9\/2014. Genentech Inc. CA USA (2014).www.gene.com\/download\/pdf\/xolair_prescribing.pdf."},{"key":"e_1_3_3_62_1","unstructured":"Xolair (75 mg powder and solvent for solution for injection). Summary of product characteristics last updated 14\/04\/2015. Novartis Europharm Limited Camberley UK. www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000606\/WC500057298.pdf."},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304048"},{"key":"e_1_3_3_64_1","first-page":"B19","article-title":"Dupilumab improves lung function and reduces severe exacerbations in uncontrolled asthma with baseline eosinophil levels above and below 300 cells\/\u03bcL","volume":"191","author":"Wenzel S","year":"2015","unstructured":"Wenzel S, Wang L, Pirozzi G et al. Dupilumab improves lung function and reduces severe exacerbations in uncontrolled asthma with baseline eosinophil levels above and below 300 cells\/\u03bcL. Am. J. Respir. Crit. Care Med. 191, B19, Abstract 68982 (2015).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"101","key":"e_1_3_3_65_1","first-page":"107","article-title":"Dupilumab in chronic sinusitis with nasal polyposis, with and without asthma","volume":"70","author":"Bachert C","year":"2015","unstructured":"Bachert C, Mannent L, Naclerio RM et al. Dupilumab in chronic sinusitis with nasal polyposis, with and without asthma. Allergy 70(Suppl. 101), 107\u2013112 (2015).","journal-title":"Allergy"},{"key":"e_1_3_3_66_1","unstructured":"ClinicalTrials Database: NCT02379052. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02379052."},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.05.042"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.11.010"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1709"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.03.003"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.10.013"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00388-8"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.12.1484"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0625.2001.100102.x"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09586.x"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1246"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jopan.2009.01.010"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1159\/000245677"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.12.1513"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1994.tb01167.x"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1983.tb09716.x"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.12.1124"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.09.031"},{"issue":"1","key":"e_1_3_3_84_1","first-page":"S29","article-title":"Dupilumab suppression of Th2 biomarkers correlates with a reduction in transepidermal water loss (TEWL) and clinical improvements in adults with moderate-to-severe atopic dermatitis (AD)","volume":"135","author":"Hamilton J","year":"2015","unstructured":"Hamilton J, Hamon S, Chaudhry U et al. Dupilumab suppression of Th2 biomarkers correlates with a reduction in transepidermal water loss (TEWL) and clinical improvements in adults with moderate-to-severe atopic dermatitis (AD). J. Investig. Dermatol. 135(Suppl. 1s), S29, Abstract 169 (2015).","journal-title":"J. Investig. Dermatol."}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt.15.69","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T10:14:45Z","timestamp":1715940885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt.15.69"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":82,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.2217\/imt.15.69"],"URL":"https:\/\/doi.org\/10.2217\/imt.15.69","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-11-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}